Molecular Markers in Treatment in Endometrial Cancer

NCT00598845UNKNOWNOBSERVATIONAL

Summary

The purpose of this prospective multicenter trial is to investigate the value of molecular markers in endometrial cancer for predicting lymph node metastasis and prognosis in relation to treatment.

Key Facts

Lead Sponsor

University of Bergen

Enrollment

1000

Start Date

2001-04-01

Completion Date

2015-12-01

Study Type

OBSERVATIONAL

Official Title

Prospective Study of Endometrial Cancer Treatment in Relation to Molecular Markers in Curettage Specimens.

Interventions

Tumor biopsy study

Conditions

Endometrial NeoplasmsNeoplasm Metastasis

Eligibility

Sex

FEMALE

Inclusion Criteria:

* Women with endometrial carcinoma
* Available endometrial biopsy
* Informed consent

Exclusion Criteria:

* No informed consent

Outcome Measures

Primary Outcomes

Presence of lymph node metastases

Time frame: At primary treatment

Secondary Outcomes

Recurrent disease, death from disease

Time frame: 5 years after primary treatment

Locations

Gynecological Oncology, UZ Gasthuisberg, Leuven, Belgium

Department of Gynecology, Ålesund Hospital, Ålesund, Norway

Sentralsykehuset i Førde, Førde, Norway

Helse-Fonna, Haugesund Sjukehus, Haugesund, Norway

Kvinneklinikken, Akershus Universitetssykehus, Lørenskog, Norway

Kvinnesenteret, Ullevål Universitetssykehus, Oslo, Norway

Department of Gynecology, St Olav's Hospital, Trondheim, Norway

Sykehuset Vestfold HF, Tønsberg, Norway

Senter for Surgical Gynecologic Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Linked Diseases

Endometrial Neoplasms

Endometrial Neoplasms — a type of gynecological cancer.